bc-ontologyGovernments, institutions, geography and law
Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

21 CFR 314.510 Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity.

21 CFR 314.510 Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity., “Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible…”, is a CFR section of 21 CFR Part 314, Subpart H—Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses; in force.

https://ontology.bommaritollc.com/id/01a0f094-c4e5-76cd-b2d9-17a3b02eef62
schema:Legislation
Download TurtleJSON-LDN-TriplesMarkdown
Cite this
21 CFR 314.510 Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c4e5-76cd-b2d9-17a3b02eef62

Elsewhere

Facts

adms:identifier
prov:wasDerivedFrom
schema:isPartOf
schema:legislationIdentifier
21 CFR 314.510
schema:legislationJurisdiction
schema:legislationLegalForce
schema:legislationType
schema:name
Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidityen
schema:url
skos:prefLabel
21 CFR 314.510 Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity.en

Related

Cited by (4)eli:cites